Selected research
Market Structure
Global Bupropion Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Bupropion Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Bupropion Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Bupropion Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Bupropion Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Bupropion Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Bupropion Tablets include GSK, Yichang Humanwell Pharmaceutical, Sinotherapeutics, CSPC Ouyi Pharmaceutical, Luye Pharma, Disha Pharmaceutical, Zydus, Watson Laboratories and TWi Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Bupropion Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Bupropion Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Bupropion Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bupropion Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.
Bupropion Tablets Segment by Company
GSK
Yichang Humanwell Pharmaceutical
Sinotherapeutics
CSPC Ouyi Pharmaceutical
Luye Pharma
Disha Pharmaceutical
Zydus
Watson Laboratories
TWi Pharmaceuticals
Sun Pharma
ScieGen Pharmaceuticals
Sandoz
Lupin
Impax Laboratories
Epic Pharma
Bausch
Aurobindo Pharma
Apotex
Alembic
Accord Healthcare
Bupropion Tablets Segment by Type
Immediate-release Tablets
Extended-release Tablets
Bupropion Tablets Segment by Application
Major Depressive Disorder
Assisted Smoking Cessation
Other
Bupropion Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bupropion Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bupropion Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bupropion Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Bupropion Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bupropion Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bupropion Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Bupropion Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Immediate-release Tablets
- Extended-release Tablets
Applications
- Major Depressive Disorder
- Assisted Smoking Cessation
- Other
Companies covered
- GSK
- Yichang Humanwell Pharmaceutical
- Sinotherapeutics
- CSPC Ouyi Pharmaceutical
- Luye Pharma
- Disha Pharmaceutical
- Zydus
- Watson Laboratories
- TWi Pharmaceuticals
- Sun Pharma
- ScieGen Pharmaceuticals
- Sandoz
- Lupin
- Impax Laboratories
- Epic Pharma
- Bausch
- Aurobindo Pharma
- Apotex
- Alembic
- Accord Healthcare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Bupropion Tablets Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Bupropion Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Bupropion Tablets Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Bupropion Tablets Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Bupropion Tablets Market Dynamics
- 2.1 Bupropion Tablets Industry Trends
- 2.2 Bupropion Tablets Industry Drivers
- 2.3 Bupropion Tablets Industry Opportunities and Challenges
- 2.4 Bupropion Tablets Industry Restraints
3 Bupropion Tablets Market by Manufacturers
- 3.1 Global Bupropion Tablets Revenue by Manufacturers (2021-2026)
- 3.2 Global Bupropion Tablets Sales by Manufacturers (2021-2026)
- 3.3 Global Bupropion Tablets Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Bupropion Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Bupropion Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Bupropion Tablets Manufacturers, Product Type & Application
- 3.7 Global Bupropion Tablets Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Bupropion Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Bupropion Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Bupropion Tablets Tier 1, Tier 2, and Tier 3
4 Bupropion Tablets Market by Type
- 4.1 Bupropion Tablets Type Introduction
- 4.1.1 Immediate-release Tablets
- 4.1.2 Extended-release Tablets
- 4.2 Global Bupropion Tablets Sales by Type
- 4.2.1 Global Bupropion Tablets Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Bupropion Tablets Sales by Type (2021-2032)
- 4.2.3 Global Bupropion Tablets Sales Market Share by Type (2021-2032)
- 4.3 Global Bupropion Tablets Revenue by Type
- 4.3.1 Global Bupropion Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Bupropion Tablets Revenue by Type (2021-2032)
- 4.3.3 Global Bupropion Tablets Revenue Market Share by Type (2021-2032)
5 Bupropion Tablets Market by Application
- 5.1 Bupropion Tablets Application Introduction
- 5.1.1 Major Depressive Disorder
- 5.1.2 Assisted Smoking Cessation
- 5.1.3 Other
- 5.2 Global Bupropion Tablets Sales by Application
- 5.2.1 Global Bupropion Tablets Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Bupropion Tablets Sales by Application (2021-2032)
- 5.2.3 Global Bupropion Tablets Sales Market Share by Application (2021-2032)
- 5.3 Global Bupropion Tablets Revenue by Application
- 5.3.1 Global Bupropion Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Bupropion Tablets Revenue by Application (2021-2032)
- 5.3.3 Global Bupropion Tablets Revenue Market Share by Application (2021-2032)
6 Global Bupropion Tablets Sales by Region
- 6.1 Global Bupropion Tablets Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Bupropion Tablets Sales by Region (2021-2032)
- 6.2.1 Global Bupropion Tablets Sales by Region (2021-2026)
- 6.2.2 Global Bupropion Tablets Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Bupropion Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Bupropion Tablets Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Bupropion Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Bupropion Tablets Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Bupropion Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Bupropion Tablets Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Bupropion Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Bupropion Tablets Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Bupropion Tablets Revenue by Region
- 7.1 Global Bupropion Tablets Revenue by Region
- 7.1.1 Global Bupropion Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Bupropion Tablets Revenue by Region (2021-2026)
- 7.1.3 Global Bupropion Tablets Revenue by Region (2027-2032)
- 7.1.4 Global Bupropion Tablets Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Bupropion Tablets Revenue (2021-2032)
- 7.2.2 North America Bupropion Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Bupropion Tablets Revenue (2021-2032)
- 7.3.2 Europe Bupropion Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Bupropion Tablets Revenue (2021-2032)
- 7.4.2 Asia-Pacific Bupropion Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Bupropion Tablets Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Bupropion Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 GSK
- 8.1.1 GSK Company Information
- 8.1.2 GSK Business Overview
- 8.1.3 GSK Bupropion Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 GSK Bupropion Tablets Product Portfolio
- 8.1.5 GSK Recent Developments
- 8.2 Yichang Humanwell Pharmaceutical
- 8.2.1 Yichang Humanwell Pharmaceutical Company Information
- 8.2.2 Yichang Humanwell Pharmaceutical Business Overview
- 8.2.3 Yichang Humanwell Pharmaceutical Bupropion Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Yichang Humanwell Pharmaceutical Bupropion Tablets Product Portfolio
- 8.2.5 Yichang Humanwell Pharmaceutical Recent Developments
- 8.3 Sinotherapeutics
- 8.3.1 Sinotherapeutics Company Information
- 8.3.2 Sinotherapeutics Business Overview
- 8.3.3 Sinotherapeutics Bupropion Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Sinotherapeutics Bupropion Tablets Product Portfolio
- 8.3.5 Sinotherapeutics Recent Developments
- 8.4 CSPC Ouyi Pharmaceutical
- 8.4.1 CSPC Ouyi Pharmaceutical Company Information
- 8.4.2 CSPC Ouyi Pharmaceutical Business Overview
- 8.4.3 CSPC Ouyi Pharmaceutical Bupropion Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 CSPC Ouyi Pharmaceutical Bupropion Tablets Product Portfolio
- 8.4.5 CSPC Ouyi Pharmaceutical Recent Developments
- 8.5 Luye Pharma
- 8.5.1 Luye Pharma Company Information
- 8.5.2 Luye Pharma Business Overview
- 8.5.3 Luye Pharma Bupropion Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Luye Pharma Bupropion Tablets Product Portfolio
- 8.5.5 Luye Pharma Recent Developments
- 8.6 Disha Pharmaceutical
- 8.6.1 Disha Pharmaceutical Company Information
- 8.6.2 Disha Pharmaceutical Business Overview
- 8.6.3 Disha Pharmaceutical Bupropion Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Disha Pharmaceutical Bupropion Tablets Product Portfolio
- 8.6.5 Disha Pharmaceutical Recent Developments
- 8.7 Zydus
- 8.7.1 Zydus Company Information
- 8.7.2 Zydus Business Overview
- 8.7.3 Zydus Bupropion Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Zydus Bupropion Tablets Product Portfolio
- 8.7.5 Zydus Recent Developments
- 8.8 Watson Laboratories
- 8.8.1 Watson Laboratories Company Information
- 8.8.2 Watson Laboratories Business Overview
- 8.8.3 Watson Laboratories Bupropion Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Watson Laboratories Bupropion Tablets Product Portfolio
- 8.8.5 Watson Laboratories Recent Developments
- 8.9 TWi Pharmaceuticals
- 8.9.1 TWi Pharmaceuticals Company Information
- 8.9.2 TWi Pharmaceuticals Business Overview
- 8.9.3 TWi Pharmaceuticals Bupropion Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 TWi Pharmaceuticals Bupropion Tablets Product Portfolio
- 8.9.5 TWi Pharmaceuticals Recent Developments
- 8.10 Sun Pharma
- 8.10.1 Sun Pharma Company Information
- 8.10.2 Sun Pharma Business Overview
- 8.10.3 Sun Pharma Bupropion Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Sun Pharma Bupropion Tablets Product Portfolio
- 8.10.5 Sun Pharma Recent Developments
- 8.11 ScieGen Pharmaceuticals
- 8.11.1 ScieGen Pharmaceuticals Company Information
- 8.11.2 ScieGen Pharmaceuticals Business Overview
- 8.11.3 ScieGen Pharmaceuticals Bupropion Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 ScieGen Pharmaceuticals Bupropion Tablets Product Portfolio
- 8.11.5 ScieGen Pharmaceuticals Recent Developments
- 8.12 Sandoz
- 8.12.1 Sandoz Company Information
- 8.12.2 Sandoz Business Overview
- 8.12.3 Sandoz Bupropion Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Sandoz Bupropion Tablets Product Portfolio
- 8.12.5 Sandoz Recent Developments
- 8.13 Lupin
- 8.13.1 Lupin Company Information
- 8.13.2 Lupin Business Overview
- 8.13.3 Lupin Bupropion Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Lupin Bupropion Tablets Product Portfolio
- 8.13.5 Lupin Recent Developments
- 8.14 Impax Laboratories
- 8.14.1 Impax Laboratories Company Information
- 8.14.2 Impax Laboratories Business Overview
- 8.14.3 Impax Laboratories Bupropion Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Impax Laboratories Bupropion Tablets Product Portfolio
- 8.14.5 Impax Laboratories Recent Developments
- 8.15 Epic Pharma
- 8.15.1 Epic Pharma Company Information
- 8.15.2 Epic Pharma Business Overview
- 8.15.3 Epic Pharma Bupropion Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Epic Pharma Bupropion Tablets Product Portfolio
- 8.15.5 Epic Pharma Recent Developments
- 8.16 Bausch
- 8.16.1 Bausch Company Information
- 8.16.2 Bausch Business Overview
- 8.16.3 Bausch Bupropion Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Bausch Bupropion Tablets Product Portfolio
- 8.16.5 Bausch Recent Developments
- 8.17 Aurobindo Pharma
- 8.17.1 Aurobindo Pharma Company Information
- 8.17.2 Aurobindo Pharma Business Overview
- 8.17.3 Aurobindo Pharma Bupropion Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Aurobindo Pharma Bupropion Tablets Product Portfolio
- 8.17.5 Aurobindo Pharma Recent Developments
- 8.18 Apotex
- 8.18.1 Apotex Company Information
- 8.18.2 Apotex Business Overview
- 8.18.3 Apotex Bupropion Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 Apotex Bupropion Tablets Product Portfolio
- 8.18.5 Apotex Recent Developments
- 8.19 Alembic
- 8.19.1 Alembic Company Information
- 8.19.2 Alembic Business Overview
- 8.19.3 Alembic Bupropion Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.19.4 Alembic Bupropion Tablets Product Portfolio
- 8.19.5 Alembic Recent Developments
- 8.20 Accord Healthcare
- 8.20.1 Accord Healthcare Company Information
- 8.20.2 Accord Healthcare Business Overview
- 8.20.3 Accord Healthcare Bupropion Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.20.4 Accord Healthcare Bupropion Tablets Product Portfolio
- 8.20.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Bupropion Tablets Value Chain Analysis
- 9.1.1 Bupropion Tablets Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Bupropion Tablets Production Mode & Process
- 9.2 Bupropion Tablets Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Bupropion Tablets Distributors
- 9.2.3 Bupropion Tablets Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst